Abstract: The present invention relates to a method for extracting circulating nucleic acids from a biological fluid. The method comprising the successive steps of providing the biological fluid supposed to contain the circulating nucleic acids. Then the biological fluid is contacted with a lysis solution comprising at least a chaotropic agent, a binding solution comprising at least a PEG derivative designed for cooperating with at least part of the circulating nucleic acids, wherein the binding solution is free of ethanol and isopropanol, and a solid support capable of capturing at least part of the circulating nucleic acid. Finally, the solid support is separated from the lysis solution, from the binding solution and from the biological fluid.

Abstract: The present invention relates to a method for extracting circulating nucleic acids from a biological fluid. The method comprising the successive steps of providing the biological fluid supposed to contain the circulating nucleic acids. Then the biological fluid is contacted with a lysis solution comprising at least a chaotropic agent, a binding solution comprising at least a PEG derivative designed for cooperating with at least part of the circulating nucleic acids, wherein the binding solution is free of ethanol and isopropanol, and a solid support capable of capturing at least part of the circulating nucleic acid. Finally, the solid support is separated from the lysis solution, from the binding solution and from the biological fluid.

Abstract: The present invention relates to a method for quantifying a plurality of miRNA, said method comprising the successive step of providing a sample comprising a plurality of cDNA, each cDNA corresponding to a miRNA. Then, the sample contacted with a plurality of pairs of tagged primers and a pair of universal primers, each tagged primer comprising a specific moiety and a tagged moiety. Subsequently, each cDNA is amplified by performing a first PCR amplification using a pair of tagged primers, wherein annealing step is performed at a first annealing temperature T1, to provide a plurality of DNA. Furthermore, each DNA is amplified by performing a second PCR amplification using the pair of universal primers, wherein annealing step is performed at a second annealing temperature T2. Finally, the concentration each cDNA in the sample is determined to deduce the concentration of each miRNA.

Abstract: The present invention relates a device for the efficient binding of nucleic acids on a microarray, comprising a reaction zone comprising a microarray, and a capture zone comprising a porous membrane substrate, wherein the capture zone is capable of specifically capturing sense strands of target molecules, whereas complementary antisense strands are captured in the reaction zone, or vice versa. The invention further envisages temperature regulating units in the device allowing to bring or keep the capture at a temperature not allowing hybridizing or binding of nucleic acid(s) to the capture molecules or to a temperature suitable for nucleic acid hybridization.

Abstract: The present invention relates to a method for performing molecular reactions in a device comprising the steps of (a) introducing one or more reagent solution(s) and an immiscible intermediate fluid into the device, wherein the device comprises a substrate, on which chemically or biochemically recognizable entities are immobilized; (b) performing molecular reactions between the immobilized chemically or biochemically recognizable entities and the reagent solution(s); or on the immobilized chemically or biochemically recognizable entities in the presence of the reagent solution(s); (c) displacing the reagent solution(s) present on the substrate by the immiscible intermediate fluid; (d) separating the immiscible intermediate fluid and the reagent solution(s); and reusing the reagent solution(s) and/or immiscible intermediate fluid for one or more repetitions of steps (a) to (e).